探索伊利诺伊州药房技术人员的职业疲劳:主题分析
Sodam Kim1, Johnson Osei1, Grace Fick1
1Department of Pharmacy Systems and Outcomes and Policy, University of Illinois at Chicago, Chicago, IL, United States.
Research in social & administrative pharmacy : RSAP
|February 21, 2026
概括
药房技术人员由于工作系统因素而经历职业疲劳. 需要处理人为因素,工作量和组织支持的干预措施,以改善技术人员的福祉和患者的结果.
科学领域:
- 药房实践 在药房实践中
- 职业健康 职业健康 职业健康
- 人类因素工程 人类因素工程
背景情况:
- 患者安全是国家优先事项,但医疗保健工作人员的福利,特别是药房技术人员的福利,往往被忽视.
- 尽管在药品安全和患者护理方面发挥着关键作用,但药房技术人员的职业疲劳尚未得到认可.
- 现有的关于职业疲劳的研究还没有充分解决药房技术人员面临的独特挑战.
研究的目的:
- 调查药房技术人员对职业疲劳的主观经验.
- 确定特定的工作系统组件,这些组件有助于或减轻伊利诺伊州社区药房技术人员的疲劳.
- 为了弥合在药房技术员工队伍中对职业疲劳的理解差距.
主要方法:
- 一种混合方法的方法,结合了定量调查和定性半结构面试.
- 利用职业疲劳的概念框架和患者安全的系统工程倡议.
- 采用横截面观测设计,对定性数据进行演性主题分析.
主要成果:
- 出现了五个主要主题:人为因素,休息和工作负载的影响,组织与技术人员价值观,支持性基础设施,以及工作生活质量与患者结果之间的联系.
- 人类因素被确定为导致疲劳恶化和减轻疲劳的重要因素.
- 高工作量经常阻止技术人员采取必要的休息,尽管休息被认为是减轻疲劳的方法.
结论:
- 职业疲劳是社区药房技术人员的一个重要问题,受到多个工作系统元素的影响.
- 确定的主题为制定有针对性的干预措施以减少疲劳提供了基础.
- 解决药房技术人员的职业疲劳问题对于提高员工福利和患者安全至关重要.
相关概念视频
01:18Interdisciplinary Care: The Health Care Team-II
2.3K
An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
2.3K
01:26Methods of Documentation II: POMR
1.5K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.5K
01:26Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
01:21Fatigue
885
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
885
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
231
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
231
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
198
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
198